Form 8-K - Current report:
SEC Accession No. 0001055726-25-000027
Filing Date
2025-05-13
Accepted
2025-05-13 16:08:16
Documents
15
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ino-20250513.htm   iXBRL 8-K 36372
2 EX-99.1 ino-33125x8kex991.htm EX-99.1 73099
6 picture3.jpg GRAPHIC 20543
  Complete submission text file 0001055726-25-000027.txt   275496

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ino-20250513.xsd EX-101.SCH 1764
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ino-20250513_lab.xml EX-101.LAB 22534
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ino-20250513_pre.xml EX-101.PRE 13035
17 EXTRACTED XBRL INSTANCE DOCUMENT ino-20250513_htm.xml XML 2824
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 25940063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)